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Background: The great majority of successfully resuscitated out-of-hos-
pital cardiac arrest (OHCA) patients will subsequently die during their ICU
and hospital stay. Several studies have previously described the main causes
of OHCA but the impact of aetiology on the outcome and the timing and value
of diagnostic procedures such as coronary angiogram remains controversial.
Methods: We analysed the causes of cardiac arrest in a prospective data-
base from a tertiary reference. We compared the mortality observed in the sub-
groups of patients with a cardiac or a non-cardiac cause of arrest.
Results: 983 patients were admitted from January 2000 to August 2008.In
patients without an obvious non-cardiac cause of arrest, a coronary angiogram
followed if necessary by a coronary angioplasty was performed at admission.
The median age was 58 years (range 84.39) and 74% were male. Past or cur-
rent cigarette smoking was noted in 54%, hypertension in 35% and hypercho-
lesterolemia in 23%. The causes of OHCA were an acute coronary syndrome
(ACS=Gr1) in 389 pts (40%), primary ventricular arrhythmia (VT-FV=Gr2) in
154 pts (16%), cardiac failure (=Gr3) in 35 pts (3%), acute respiratory failure
(=Gr4) in 186 pts (19%), neurological failure (=Gr5) in 41 pts (4%), unknown
(=Gr6) in 71 pts (7%) and others causes(=Gr7) in 104 pts (11%). Overall, the
mortality rate of the entire cohort was 68%; mortality rates observed in each
subgroup are displayed in the figure. 
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Introduction: Central venous oxygen saturation (SvO2) provides an accu-
rate assessment of oxygen delivery and organs consumption balance, and cor-
relate with outcome in extra cardiac shock. Its prognosis value has never been
specifically validated in heart failure patients with cardiogenic shock.
Methods: SvO2 was prospectively assessed in 27 patients (60±17 years, 17
male, LVEF=25±6%) admitted for heart failure with cardiogenic shock. SvO2
before and after 24 hours (24H SvO2) of intra-venous inotropic and diuretic
support in patients with cardiogenic shock was compared to control subject
with compensate heart failure (n=12) and to in hospital outcome (death and
heart transplant).
Results: During hospitalisation period, major cardiovascular event
occurred in 10 (36%) patients (6 deaths, 4 heart transplants). In patients with
cardiogenic shock, admission SvO2 was lower than in patients with compen-
sated heart failure (50±12, 66±6, 95% CI>58%) but increased after 24H of
treatment (50±12, 59±8, p=0.002). Importantly, improvement in Sv02 at 24H
(>58%, n=15) was associated with an excellent in hospital outcome (93%, 14/
15), while a persistently low ScvO2 at 24H (< 58%) correlated with the occur-
rence of major cardiac adverse outcome (75%, 9/12).
Furthermore, there was no difference regarding to clinical or echographical
features between event free and poor outcome groups.
Conclusion: Change in SvO2 under intra-venous inotropic and diuretic
treatment is a strong predictor of outcome in patients with cardiogenic shock. 
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Background: Type B aortic syndrome is one of the most life-threatening
aortic condition. The management of descending aortic diseases remains con-
troversial. The aim of this study was to compare the results of medical and
endovascular treatments of type B aortic syndromes.
Method: The medical records of patients with type B aortic syndrome
between 2000 and 2009 were retrospectively revised. Type B aortic syndromes
consisted of acute aortic dissection (n= 71), chronic aortic dissection (n=32),
aortic hematoma (n=27) or penetrating ulcers (n=4). Patients with traumatic
aortic ruptures were excluded. The population was divided into two groups.
Patients of group A were medically treated (n=76) and patients of group B
underwent endovascular management (n= 58). Short and long term outcomes
were compared. The median follow up was 28.5 months.
Results: Mean age was 66.3±11.6 years old. The sex ratio was 2.83 (Male/
Female).In group B, past history of type A aortic dissection were more frequent
(p<.05) and mean aortic diameter of the descending thoracic aorta was higher
(p<.0001). There were no other statically significant differences between the
two groups. Overall in-hospital mortality was 11.8% in group A and 8.6% in
group B (p=0.53). Overall survivals at one year were respectively 84.3% and
88% in group A and B (p=0.54). Overall survivals at five years were respec-
tively 72.4% and 81.1% in group A and B (p=0.2). However a significant dif-
ference in mortality appeared at nine years follow up, giving the advantage to
the endovascular treatment according to Kaplan-Meier estimates (p<0.05).
Conclusion: In hospital mortality and mild term results were not different
between the two groups. Long term results seemed to be better in the endovas-
cular group. These results suggest the potential interest of endovascular man-
agement of type B aortic syndrome particularly in term of long term survival.
This point has to be confirmed in larger populations and longer follow up.
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Introduction: Diagnostic value of circulating D-Dimer (DD) in acute
aortic dissection (AAD) has been shown recently. However, there is no data
concerning the kinetics of DD in AAD and few is known about prognostic
value of DD in AAD.
Objectives: to describe the kinetics of circulating DD during the in-hos-
pital period of AAD in patients and to analyse its prognostic value.
Patients and Methods: consecutive patients presenting with AAD in our
institution were included. Follow-up was obtained to determine the total mor-
tality and major events related to AAD i.e. :re-intervention, aneurismal evolu-
tion, persistence of a circulating false lumen). DD were assessed by
immunoturbidimetric method (Stago®, France).
Results: 109 patients (mean age 62 ± 14 years) were included. 76
patients were Stanford A (70%, surgery in 97%), and 33 Stanford B (30%,
surgery in 9%). DD levels at admission were 10032 ± 7955 ng/ml. The
kinetic of DD followed a “V” curve with a significant decrease until day 2
(nadir) and a slow increase thereafter up to day 8 without difference between
the type of dissection or whether the patients were operated or not. Cumula-
tive mortality was 16% in-hospital and 28 % at a mean of follow up 3.4 ± 3
years. In-hospital mortality was associated with DD level at admission and
at day2 (nadir). Cumulative long-term mortality was only associated with
DD level at day 2 (nadir) at the cut off of 2000ng/ml. DD were not associ-
ated with re-intervention, aneurismal evolution or persistence of a circulating
false lumen.
Conclusion: DD kinetic in AAD follows a biphasic “V” curve, with a
nadir at day 2. In hospital mortality is associated with DD at admission and at
day2, whereas cumulative long-term mortality is only associated with DD
levels at day 2. These results suggest that a DD dosage at admission and at day
2 in AAD might be of help for the patient prognosis evaluation.
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Background: The 2006 French recommendations concerning acute myo-
cardial infarction management occurring out of cardiologic unit recommend a
close control of glycemia. The aim of our study was to assess spread of these
recommendations.
Methods: We conducted in 2008 a national phone survey in coronary care
units (CCU) and out-of-hospital mobile emergency units (SMUR). Senior phy-
sicians were asked about local hyperglycemia protocol management for
patients with acute coronary syndrome (ACS).
Results: The mains answers from the cardiologists and the emergency phy-
sicians (EP) are listed in the table. 
Only 50 percent of the SMUR have insulin for out of hospital treatment. In
the CCU the first result of glycemia is a capillary dosage for 64% and a blood
dosage for 36%.
The glycemia threshold for the insulin treatment ranges from 1 to 3 g/l. For
14% of EP there is no indication of hyperglycemia treatment during the out of
hospital management of ACS. For 99% of cardiologists there is an indication
of treatment by insulin for hyperglycemia during the ACS.
Conclusion: The early management of hyperglycemia in patients with
ACS is more widespread in CCU than in out of hospital emergency context.
Recommendations concerning early hyperglycemia management in patients
with ACS have to be more spread among emergency physicians.
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Failure of myocardial perfusion after coronary angioplasty for acute myo-
cardial infarction (AMI) is associated with a poor prognosis. Grade 3 ischemia
(G3I) was shown to be associated with failure of myocardial perfusion.
Aim: Evaluate the prognosis impact of G3i, recorded on the admission
electrocardiogram, after percutaneous coronary intervention (PCI) for AMI.
Methods: One hundred eight patients had PCI in the setting of AMI. G3I
was defined as: Absence of S wave below the TP-PR isoelectric line in > 2
leads. Patients meeting the ST-elevation criteria but not the G3I criteria were
classified as grade 2 ischemia (G2I). Myocardial perfusion was evaluated on
ST-segment resolution and angiographyally on the flow of infarct-related
artery graded according to the TIMI scale. Occurrence of no-reflow, no ST-
segment resolution and hospital mortality were evaluated.
Results: Patients were divided in 2 groups: G3I (51 patients) and G2I. (57
patients). Clinical and angiographic characteristics were similar, absence of
ST-segment resolution; the no-reflow phenomena and hospital mortality were
more common in the G3I group respectively: 47% vs 20 % (p= 0.002), 27%
vs 10% (p = 0,024) and 21,.6% Vs 8.8% (p = 0.062). IG3, female gender, dia-
betes and delay to consultation > 2 hours were associated with the occurrence
of no-reflow, persistence of ST- segment elevation and hospital death. In mul-
tivariate analysis, IG3 was an independent factor of no-reflow and absence of
ST- segment resolution: OR 3.45 (CI 95% [1.15 to10.31]) p=0.027 and OR
3.47 (CI 95% [1.37 to9.01]) p=0.011, respectively. Female gender, no-reflow
and persistence of ST-segment elevation were the only independent predictive
factors of hospital mortality, respectively : OR 10,59 (CI 95% [1,68 to66,8])
p=0,012 ; OR 7,39 (CI 95% [1,52 to35,8]) p=0,013 ; OR 50 (CI 95% [4,69
to532]) p=0,001 but not the grade 3 ischemia.
Conclusion: Grade 3 ischemia on the admission electrocardiogram of acute
myocardial infarction is a strong independent predictors of failure of tissular
reperfusion.
 CCU 
n=125
SMUR 
n=245
Systematic glycemia dosage in patients with chest pain 55 % 55 %
Systematic glycemia dosage in patients with ACS 59 % 63 %
Specific insulin protocol in patients with ACS 55 14
Same hyperglycemia treatment for diabetic 
and non diabetic patient
52 % 62 %
% of physicians who have already treated 
hyperglycemia during ACS
98 % 37 %
